Scholarly Index
Maxine Sun
Dana-Farber Cancer Institute; 24,662 total citations; 731 total publications; best world rank #80
Dana-Farber Cancer Institute
24,662Total citations
731Total publications
81H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal cell carcinoma treatment | Lifetime | 80 | US 56 | 99.46 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 94 | US 62 | 99.50 |
| Renal and related cancers | Lifetime | 188 | US 109 | 98.95 |
| Urinary and Genital Oncology Studies | Lifetime | 119 | US 74 | 99.11 |
| Urological Disorders and Treatments | Lifetime | 242 | US 152 | 98.83 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 266 | US 143 | 99.14 |
| Prostate Cancer Treatment and Research | Lifetime | 352 | US 203 | 98.96 |
| Multiple and Secondary Primary Cancers | Lifetime | 154 | US 65 | 98.16 |
| Economic and Financial Impacts of Cancer | Lifetime | 211 | US 141 | 97.46 |
| Cancer Diagnosis and Treatment | Lifetime | 706 | US 323 | 96.72 |
| Urologic and reproductive health conditions | Lifetime | 629 | US 304 | 96.31 |
| Ferroptosis and cancer prognosis | Lifetime | 918 | US 187 | 92.70 |
| Genital Health and Disease | Lifetime | 855 | US 369 | 93.56 |